Tesofensine vs Cotadutide

Head-to-head comparison of Tesofensine (Tesofensine (NS2330)) and Cotadutide (MEDI0382, long-acting GLP-1 and glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyTesofensineCotadutide
CategoryWeight ManagementWeight Management
Full NameTesofensine (NS2330)MEDI0382, long-acting GLP-1 and glucagon receptor dual agonist
Molecular Weight426.52 g/mol~4,700 Da
Half-Life~200-300 hoursApproximately 24 hours
Amino AcidsSmall molecule37
Typical Dose0.3-3 mg daily in clinical studies
RouteSubcutaneous
Purity>98%≥98%
Studies Count3518
Research StatusPhase III Clinical TrialsClinical

Tesofensine Benefits

  • Potent appetite suppression, increased metabolic rate, enhanced thermogenesis, improved mood during dieting, reduces food reward-seeking behavior

Cotadutide Benefits

  • body-weight reduction
  • improved insulin sensitivity
  • reduced hepatic fat
  • appetite suppression

Tesofensine Dosing

Clinical doses: 0.25-1.0 mg orally once daily. Research typically uses 0.5 mg. Extremely long half-life (8-13 days) means steady-state in 7-10 days.

Cotadutide Dosing

Once-daily SC in trials|Start low and titrate based on tolerance|Monitor GI adverse effects

Tesofensine Side Effects

  • Dry mouth, insomnia, constipation, increased heart rate, elevated blood pressure. Not recommended with uncontrolled hypertension.

Cotadutide Side Effects

  • nausea
  • vomiting
  • diarrhea

Research Overview

Tesofensine

Phase II trials showed 12.8 kg average weight loss at 1.0 mg dose over 6 months. Simultaneously inhibits reuptake of norepinephrine, dopamine, and serotonin, producing appetite suppression and increased thermogenesis.

Cotadutide

Phase 2 studies reported dose-dependent weight loss and favorable changes in glycemic and liver-related markers. It is one of the most cited synthetic dual-agonist peptides for obesity research.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Tesofensine stacks with:

5-Amino-1MQAOD-9604MOTS-c

Cotadutide stacks with:

dietary-calorie-restrictionexercise-program
weight-lossappetite-suppressanttriple-reuptake-inhibitorthermogenesisGLP-1glucagon-coagonistdual-agonistobesity-research